MedTrace Logo

Longitudinal Study of the Patients With Medication-overuse Headache or Migraine That Completed Baseline MRI

NCT05528081 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2022-10-19

No results posted yet for this study

Summary

This is a phone interview research study for patients with migraine or medication-overuse headache (MOH) who have completed baseline MRI scans. Participants will be interviewed by phone at 3, 12, 24 months after the baseline MRI scans.

The purpose of this study is to potentially identify the baseline brain functional or structural signatures (functional connectivity, regional homogeneity, amplitude of low frequency fluctuation, and so such) that are predictive of the short- and long- term outcomes as well as treatment response of migraine and MOH patients.

Conditions

  • Migraine Disorders
  • Medication-overuse Headache

Interventions

OTHER

Phone interview

Participants will be interviewed by phone at 3, 12, 24 months after the baseline MRI scans.

Sponsors & Collaborators

  • International Headache Society

    collaborator UNKNOWN

  • Wei Dai

    lead OTHER

Principal Investigators

  • Wei Dai, M.D. · Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-10-01
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05528081 on ClinicalTrials.gov